首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>>
免疫调节
>>
免疫球蛋白/Fc相关
>
Human ARL6IP6 Protein, mFc Tag
Human ARL6IP6 Protein, mFc Tag

Human ARL6IP6 Protein, mFc Tag

产品编号

KMP3157

别名

ADP 核糖基化因子样 GTPase 6 相互作用蛋白 6, Human ARL6IP6 Protein, mFc Tag, ARL6IP6

目录价格

联系客服获取报价RMB

规格
  • 50ug
  • 100ug
  • 200ug
产品介绍
AliasADP 核糖基化因子样 GTPase 6 相互作用蛋白 6, Human ARL6IP6 Protein, mFc Tag, ARL6IP6
Catalog NumberKMP3157
Product DescriptionThe Human ARL6IP6 Protein(KMP3157) is produced in HEK293 Cells. The target gene encoding the human ARL6IP6 (NP_689735.1) (Met1-Ser110) is expressed with the Fc region of mouse IgG1 at the N-terminus.
Molecular NameARL6IP6
SpeciesHuman
HostHEK293 Cells
Size50ug, 100ug, 200ug
Protein FamilyOther protein
Purity>95% as determined by SDS-PAGE
Concentration联系销售经理获得最新批次的浓度
PurificationAffinity purification
Endotoxin<1.0 EU/ug determined by the LAL method
FormulationPBS, pH7.4
BackgroundIt had been found that a homozygous truncating mutation in ARL6IP6 as the likely cause of a syndromic form of CMTC associated with major dysmorphism, developmental delay, transient ischemic attacks and cerebral vascular malformations. This gene was previously implicated by genome wide association study (GWAS) as a susceptibility locus to ischemic stroke in young adults. We identify ARL6IP6 as a novel candidate gene for a syndromic form of CMTC. This suggests that ischemic stroke or transient ischemic attacks (TIA) may represent, at least in some cases, the mild end of a phenotypic spectrum that has at its severe end autosomal recessive CMTC. This finding contributes to a growing appreciation of the continuum of Mendelian and common complex diseases.
ApplicationWB, ELISA
Recommended DilutionELISA: 1:100-1:1000
Cross-reactivityNo cross-reactivity with other antigens or proteins.
Predicted Molecular Weight38.6 kDa
Predicted N TerminusMet
ReconstitutionNot applicable. The product is supplied as a ready-to-use liquid formulation.
Storage ConditionAliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.
Remarks收到产品后请立即按保存条件储存;使用前短暂离心,使内容物集中于管底;避免反复冻融。
Shipping ConditionIn general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. If supplied as liquid, the proteins will be shipped with dry ice.
StabilitySamples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Molecular Weight38.6 kDa
Cross-reactivityNo cross-reactivity with other antigens or proteins.
Note仅供科研使用
ELISA IC50(ppb)≥ 1:1000
FunctionIt had been found that a homozygous truncating mutation in ARL6IP6 as the likely cause of a syndromic form of CMTC associated with major dysmorphism, developmental delay, transient ischemic attacks and cerebral vascular malformations. This gene was previously implicated by genome wide association study (GWAS) as a susceptibility locus to ischemic stroke in young adults. We identify ARL6IP6 as a novel candidate gene for a syndromic form of CMTC. This suggests that ischemic stroke or transient ischemic attacks (TIA) may represent, at least in some cases, the mild end of a phenotypic spectrum that has at its severe end autosomal recessive CMTC. This finding contributes to a growing appreciation of the continuum of Mendelian and common complex diseases.
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
Temperature Range-20℃ ~ -80℃
Solubility产品为即用型液体,无需复溶。
AppearanceLiquid
Product Full NameHuman ARL6IP6 Protein
Preservative SolutionPBS, pH7.4
Usage Method冻干粉请按“复溶”说明用无菌去离子水复溶后使用,液体产品可直接使用;具体工作浓度请参考“推荐稀释比例”。
TargetARL6IP6

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价